DSM takes stake in chiral compound specialist
DSM has taken a 25 per cent interest in Nijmegen, Netherlands-based Chiralix in move which both expands DSM's capabilities in early-stage drug development and Chiralix' position in stereochemistry
Archives for July 3, 2003
Biotrace taps into Scandinavia with Maltec buy
Microbiology specialist Biotrace has continued its expansion into the healthcare sector with the acquisition of Denmark's Maltec, helping it to target Scandinavia's strong pharma sector
FDA rebuffs Akzo fertility product
Akzo Nobel received a knock-back from the US Food and Drug Administration after the agency asked for more information before approving a ready-to-use version of the firm's fertility drug Follistim.
Millipore sees throw-away future
The shift towards full automation with ready-to-use separation devices is the first step on the path to a completely disposable manufacturing process, says Millipore
Millennium takes Xenova's cancer drug into clinic
A UK Phase I trial has been initiated for XR5944 (also known as MLN944), a DNA targeting agent under evaluation for the treatment of advanced cancers. The product is under development by USA-based firm Millennium Pharmaceuticals and the UK's Xenova.
Ultrasound improves biopharma purification
Ultrasound monitoring of process column chromatography can lead to significant improvements in productivity, lower costs and greater drug purity, says study
Caliper gets OK for Zymark purchase
Caliper Technologies has been given the go-ahead by the US federal Trade Commission for its $71 million cash and stock acquisition of Zymark, a specialist in laboratory automation and robotics equipment.